Fidelity Investments’s MapLight Therapeutics MPLT Stock Holding History
Bought
Maintained
Sold
Other funds holding MPLT
Fidelity Investments's MPLT Position: Q3 2026 in Review
Fidelity Investments increased its MapLight Therapeutics (MPLT) stake by 87% in Q3 2026, buying an estimated $13.5M and bringing the position to 1,541,940 shares worth $15.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1970.
Fidelity Investments first reported a position in MPLT in Q4 2025 and has held it in 4 quarters since. The position peaked at $29.5M in Q2 2026. 60 funds tracked by Wall St. Rank hold MPLT as of Q3 2026.
- Fidelity Investments held 1,541,940 shares of MapLight Therapeutics worth $15.7M as of Q3 2026.
- Fidelity Investments bought 718,384 MapLight Therapeutics shares in Q3 2026, an estimated $13.5M.
- MapLight Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #1970 holding.
- Fidelity Investments first reported a position in MapLight Therapeutics in Q4 2025 and has held it in 4 quarters since.
- Fidelity Investments's MapLight Therapeutics position peaked at $29.5M in Q2 2026.
- 60 funds tracked by Wall St. Rank held MapLight Therapeutics as of Q3 2026.
Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.